This inventor holds 3 USPTO granted patents. Top assignee: Novartis Ag. Active years: 1998-2001.
Company Filing History:
Years Active: 1998-2001
Title: The Innovations of Soo Young Ko
Introduction
Soo Young Ko is a prominent inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cyclosporin derivatives. With a total of 3 patents to his name, his work has the potential to impact the treatment of serious health conditions.
Latest Patents
One of his latest patents focuses on a cyclosporin fermentation process. This innovation has been found to produce nonimmunosuppressive, cyclophilin-binding cyclosporins that are useful in the treatment and prevention of AIDS and AIDS-related disorders. The cyclosporins developed by Soo Young Ko include novel derivatives modified at the 4- and/or 5-positions, showcasing his commitment to advancing medical science.
Career Highlights
Soo Young Ko is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field, further enhancing the impact of his inventions.
Collaborations
Some of his notable coworkers include Hans Kobel and Brigitte Besemer-Rosenwirth. Their collaboration has contributed to the innovative environment at Novartis, fostering advancements in pharmaceutical research.
Conclusion
Soo Young Ko's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for new treatments and innovations in healthcare.